Differential apoptosis by indomethacin in gastric epithelial cells through the constitutive expression of wild-type p53 and/or up-regulation of c-myc

Biochemical Pharmacology

Volumn 58, Issue 1, 1999, Pages 193-200

  Zhu, Geng Hui ^a   Wong, Benjamin Chun Yu ^a   Ching, Chi Kong ^a   Lai, Kam Chuen ^a   Lam, Shiu Kum ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Apoptosis; Cell cycle; Chemoprevention; NSAIDs; Oncogene; Stomach

Indexed keywords

INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT; PROTEIN P53;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL GROWTH; CONTROLLED STUDY; FIBROBLAST; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; NORTHERN BLOTTING; ONCOGENE C MYC; PRIORITY JOURNAL; STOMACH CANCER; STOMACH EPITHELIUM;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; APOPTOSIS; CELL CYCLE; CELL DIVISION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; EPITHELIAL CELLS; GENE EXPRESSION; GENES, MYC; HUMANS; INDOMETHACIN; RNA, MESSENGER; STOMACH; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 0033169028     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(99)00058-1     Document Type: Article

References (51)

1. Kerr J.F.R., Willie A.H., Currie A.R. Apoptosis A basic biological phenomenon with wide-ranging implications in tissue kinetics . Br J Cancer. 26:1972;239-257.
2. Que F.G., Gores G.J. Cell death by apoptosis Basic concepts and disease relevance for the gastroenterologist . Gastroenterology. 110:1996;1238-1243.
3. Lane D.P. P53, guardian of the genome. Nature. 358:1992;15-16.
4. Farmer G., Bargonetti J., Zhu H., Friedman P., Prywes R., Prives C. Wild-type p53 activates transcription in vivo. Nature. 358:1992;83-86.
5. El-Deiry W.S., Tokino T., Velculescu V.E., Levy D.B., Parsons R., Trent J.M., Lin D., Mercer W.E., Kinzler K.W., Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell. 75:1993;817-825.
6. El-Deiry W.S., Harper J.W., O'Connor P.M., Velculescu V.E., Canman C.E., Jackman J., Pietenpol J.A., Burrell M., Hill D.E., Wang Y., Wiman K.G., Mercer W.E., Kastan M.B., Kohn K.W., Elledge S.J., Kinzler K.W., Vogelstein B. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res. 54:1994;1169-1174.
7. WAF1/CIP1/SDI1 in differentiating human leukemic cells. J Clin Invest. 95:1995;973-979.
8. Steinman R.A., Hoffman B., Iro A., Guillouf C., Liebermann D.A., El-Houseini M.E. Induction of p21 (WAF-1/CIP1) during differentiation. Oncogene. 9:1994;3389-3396.
9. Chiou S.K., Rao L., White E. Bcl-2 blocks p53-dependent apoptosis. Mol Cell Biol. 14:1994;2556-2563.
10. Correa P. Human gastric carcinogenesis A multistep and multifactorial process-First American Cancer Society Award Lecture on cancer epidemiology and prevention . Cancer Res. 52:1996;6735-6740.
11. Yokozaki H., Kuniyasu H., Kitadai Y., Nishimura K., Todo H., Ayhan A., Yasui W., Ito H., Tahara E. p53 point mutations in primary human gastric carcinomas. J Cancer Res Clin Oncol. 119:1992;67-70.
12. Lowe S.W., Jacks T., Housman D.E., Ruley H.E. Abrogation of oncogene-associated apoptosis allows transformation of p53-deficient cells. Proc Natl Acad Sci USA. 91:1994;2026-2030.
13. Symonds H., Krall L., Remington L., Saenz-Robles M., Lowe S., Jacks T., van Dyke T. p53-dependent apoptosis suppresses tumor growth and progression in vivo. Cell. 78:1994;703-711.
14. Lowe S.W., Ruley H.W., Jacks T., Housman D.E. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell. 74:1993;957-967.
15. Lowe S.W., Bodis S., McClatchey A., Remington L., Ruley H.E., Fisher D.E., Housman D.E., Jacks T. p53 status and the efficacy of cancer therapy in vivo. Science. 266:1994;807-810.
16. Onoda N., Maeda K., Chung Y.S., Yano Y., Matsui-Yuasa I., Otani S., Sowa M. Overexpression of c-myc messenger RNA in primary and metastatic lesions of carcinoma of the stomach. J Am Coll Surg. 182:1996;55-59.
17. Tatsuta M., Iishi H., Baba M., Nakaizumi A., Uehara H., Taniguchi H. Expression of c-myc mRNA as an aid in histologic differentiation of adenoma from well-differentiated adenocarcinoma in the stomach. Cancer. 19:1994;1795-1799.
18. Askew D.S., Ashmun R.A., Simmons B.C., Cleveland J.L. Constitutive c-myc expression in IL-3-dependent myeloid cell line suppresses cycle arrest and accelerated apoptosis. Oncogene. 6:1991;1915-1922.
19. Evan G., Willie A., Gilbert C.S., Littlewood T., Land H., Brooks M., Waters C., Penn L.Z., Hancock D.C. Induction of apoptosis in fibroblasts by c-Myc protein. Cell. 69:1992;119-128.
20. Shi Y., Glynn J.M., Guilbert L.J., Cotter T.G., Bissonnette R.P., Green D.R. Role for c-myc in activation-induced apoptotic cell death in T-cell hybridoma. Science. 257:1992;212-214.
21. Hermeking H., Eick D. Mediation of c-Myc-induced apoptosis by p53. Science. 265:1994;2091-2093.
22. Giovannucci E., Rimm E.B., Stampfer M.J., Colditz G.A., Ascherio A., Willett W.C. Aspirin use and the risk for colorectal cancer in male health professionals. Ann Intern Med. 121:1994;241-246.
23. Gridley G., McLaughlin J.K., Ekbom A., Klareskog L., Adami H.O., Hacker D.G., Hoover R., Fraumeni J.F. Jr. Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst. 85:1993;307-311.
24. Piazza G.A., Kulchak Rahm A.L., Krutzsch M., Sperl G., Shipp Paranka N., Gross P.H., Brendel K., Burt R.W., Alberts D.S., Pamukcu R., Ahnen D.J. Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis. Cancer Res. 55:1995;3110-3116.
25. Thun M.J., Namboodiri M.M., Calle E.E., Flanders W.D., Heath C.W. Jr. Aspirin use and risk of fetal cancer. Cancer Res. 53:1993;1322-1327.
26. Hanif R., Pittas A., Feng Y., Koutsos M.I., Qiao L., Coico L.S., Shiff A.I., Rigas B. Effect of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway. Biochem Pharmacol. 52:1996;237-245.
27. Shiff S.J., Qiao L., Tsai L., Rigas B. Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells. J Clin Invest. 96:1995;491-503.
28. Shiff S.J., Koutsos M.I., Qiao L., Rigas B. Nonsteroidal anti-inflammatory drugs inhibit the proliferation of colon adenocarcinoma cell Effects on cell cycle and apoptosis . Exp Cell Res. 222:1996;179-188.
29. Matozaki T., Sakamoto C., Matsuda K., Suzuki T., Konda Y., Nakano O., Wada K., Uchida T., Nishisaki H., Nagao M., Kasuga M. Missense mutations and a deletion of the p53 gene in human gastric cancer. Biochem Biophys Res Commun. 182:1992;215-223.
30. Carmichael J., Mitchell J.B., DeGraff W.G., Gamson J., Gazder A.F., Johnson B.E., Glatstein E., Minna J.D. Chemosensitivity testing of human lung cancer cell lines using the MTT assay. Br J Cancer. 57:1985;540-547.
31. Lu X., Xi W.L., Reed D., Bradshaw W., Simmons D.L. Nonsteroidal anti-inflammatory drugs cause apoptosis and induce cyclooxygenases in chicken embryo fibroblasts. Proc Natl Acad Sci USA. 92:1995;7961-7965.
32. Elder D.J.E., Hague A., Hicks D.J., Paraskeva C. Differential growth inhibition by the aspirin metabolite salicylate in human colorectal tumor cell lines Enhanced apoptosis in carcinoma and in vitro-transformed adenoma relative to adenoma cell lines . Cancer Res. 56:1996;2273-2276.
33. Darzynkiewicz Z., Bruno S., del Bino S., Gorczyca W., Hotz M.A., Lassota P., Traganos F. Features of apoptotic cells by flow cytometry. Cytometry. 13:1992;795-808.
34. Grant S., Jarvis W.D., Swerdlow P.S., Turner A.J., Traylor R.S., Wallace H.F., Lin P.S., Pettit G.R., Gewirtz D.A. Potentiation of the activity of 1-β-D-arabinofuranosycytosine by the macrocyclic lactone PKC activator bryostatin 1 is associated with enhanced fragmentation of mature DNA. Cancer Res. 52:1992;6270-6278.
35. Rhoads R.E. Ovalbumin messager ribonucleic acid. J Biol Chem. 250:1975;8088-8097.
36. Ausubel F.M., Brent R., Kingston R.E., Moore D.D., Seidman J.G., Smith J.A., Struhl K. Current Protocols in Molecular Biology, Vol. 1 4.9.1. 1995;John Wiley & Sons, Inc, NY.
37. Li Y., Davis K.L., Sytkowski A.J. Protein kinase C-ε is necessary for erythropoietin's upregulation of c-myc and for factor-dependent DNA synthesis. J Biol Chem. 271:1996;27025-27030.
38. Ishida M., Gomyo Y., Ohfuji S., Ikeda M., Kawasaki H., Ito H. Evidence that expression of a mutated p53 gene attenuates apoptotic cell death in human gastric intestinal-type carcinoma in vivo. Jpn J Cancer Res. 88:1997;468-475.
39. Colombel M., Radvanyi F., Blanche M., Abbou C., Buttyan R., Donehower L.A., Chopin D., Thiery J.P. Androgen-suppressed apoptosis is modified in p53-deficient mice. Oncogene. 10:1995;1269-1274.
40. Goldberg Y., Nassif I.I., Pittas A., Tsai L.L., Dynlacht B.D., Rigas B., Shiff S.J. The antiproliferative effect of sulindac and sulindac sulfide on HT-29 colon cancer cells Alterations in tumor suppressor and cell cycle-regulatory proteins . Oncogene. 12:1996;893-901.
41. Rodrigues N.R., Rowan A., Smith M.E., Kerr I.B., Bodmer W.E., Gannon J.V., Lane D.P. p53 mutations in colorectal cancer. Proc Natl Acad Sci USA. 87:1990;7555-7559.
42. Chen Y., Chen P.L., Lee W.H. Hot-spot p53 mutants interact specifically with two cellular proteins during progression of the cell cycle. Mol Cell Biol. 14:1994;6764-6772.
43. Chin K.V., Ueda K., Pastan I., Gottesman M.M. Modulation of activity of the promoter of the human MDR1 gene by Ras and p53. Science. 255:1992;459-462.
44. Akama Y., Yasui W., Kuniyasu H., Yokozaki H., Akagi M., Tahara H., Ishikawa T., Yahara E. Genetics status and expression of the cyclin-dependent kinase inhibitors in human gastric carcinoma cell lines. Jpn J Cancer Res. 87:1996;824-830.
45. Saito Y., Ogawa K. Wild-type p53 and c-myc co-operation in generating apoptosis of a rat hepatocellular carcinoma cell line (FAA-HTC1). Oncogene. 11:1995;1013-1018.
46. Sakamuro D., Eviner V., Elliott K.J., Showe L., White E., Prendergast G.C. C-Myc induces apoptosis in epithelial cells by both p53-dependent and p53-independent mechanisms. Oncogene. 11:1995;2411-2418.
47. waf1/cip1. Gene Dev. 8:1994;2817-2830.
48. Hvidberg E., Lausen H.H., Jansen J.A. Indomethacin Plasma concentrations and protein binding in man . Eur J Clin Pharmacol. 4:1972;119-124.
49. Kaldestad E., Hansen T., Brath H.K. Interaction of indomethacin and acetylsalicylic acid as shown by the serum concentrations of indomethacin and salicylate. Eur J Clin Pharmacol. 9:1975;199-207.
50. Brune K., Gubler H., Schweitzer A. Autoradiographic methods for the evaluation of ulcerogenic effects of anti-inflammatory drugs. Pharmacol Ther. 5:1979;199-207.
51. Martin B.K. Accumulation of drug anions in gastric mucosal cells. Nature. 198:1963;896-897.